Product Information
FONDAPARINUX 2.5 MG/0.5 ML SYR is a generic product labeled by Sandoz Inc., priced at $22.1623 per ML under NDC 00781344395. Its NADAC has been published 131 times since Jan 27, 2021.
FDA first approved this application on May 15, 2018.
Strength
2.5 mg/.5mL
Manufacturer
Sandoz Inc.NDC
00781344395
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206812FDA Approved
5/15/2018
On Market Since
6/18/2019
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has been published 131 times since Jan 27, 2021, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.1623 per ML |
|---|---|
| All-time high | $40.3736 (Mar 10, 2021) |
| All-time low | $18.9706 (Apr 22, 2026) |
| 52-week high | $26.4983 |
| 52-week low | $18.9706 |
| Median price | $25.8933 |
| Average price | $25.6302 |
| Largest weekly change | -39.2% (May 22, 2024) |
| Weeks tracked | 131 |
| Tracking since | Jan 27, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fondaparinux Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor Xa Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FONDAPARINUX 2.5 MG/0.5 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 2.5 MG/0.5 ML SYR, manufactured by Sandoz Inc., is $22.1623 per ML (NDC 00781344395), effective Sep 30, 2026.
How has the price of FONDAPARINUX 2.5 MG/0.5 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has declined 45.1%. It has been tracked across 131 weekly CMS publications since Jan 27, 2021.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 2.5 MG/0.5 ML SYR?
Since Jan 27, 2021, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has ranged from a low of $18.9706 (Apr 22, 2026) to a high of $40.3736 (Mar 10, 2021), with a median of $25.8933 per ML.
Are there cheaper alternatives to FONDAPARINUX 2.5 MG/0.5 ML SYR?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FONDAPARINUX 2.5 MG/0.5 ML SYR, is $12.1247 per ML — about 45% below FONDAPARINUX 2.5 MG/0.5 ML SYR.
Who manufactures FONDAPARINUX 2.5 MG/0.5 ML SYR?
FONDAPARINUX 2.5 MG/0.5 ML SYR (NDC 00781344395) is labeled by Sandoz Inc., and CMS classifies it as a generic product.